Honeywell opens Munich Technical Centre

Published: 20-Jun-2011
Finance Analysis

Will provide German customers with support, training and centralised repair and maintenance services

Honeywell has opened a new Technical Centre in Munich, Germany to provide gas detection customers in the country with additional local services such as customer support, a training centre, and centralised repair and equipment maintenance services. The site will also house project engineering and r&d teams.

Ingo Löffler, Honeywell’s sales leader Semi/Hi-Tech EMEAI, said: ‘The new Technical Centre will enable us to deliver a more effective service, enhance our customer support and provide an easy to access training location for German and European customers. The Project Engineering and R&D teams on-site will also help us to develop tailor-made systems to specifically meet the needs of German customers.’

The 1,800m2 Technical Centre will include three fully equipped training suites, where customers can gain knowledge of a wide range of topics from the basics of gas detection to master classes on topics such as product certification.

See more

You may also like

Regulatory

Honeywell acquires life science-focused QMS provider

Read more
The acquisition further strengthens Honeywell's leadership in industrial automation, digital transformation solutions and enterprise performance management software

Trending Articles

  1. Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
  2. GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors GSK has agreed to acquire clinical-stage oncology company Nuvalent for $10.6bn, securing two late-stage next-generation kinase inhibitors — zidesamtinib and neladalkib — currently under FDA review for potential 2026 approval in non-small cell lung cancer
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum From a $86.6m Series B for first-in-class ADCs to a $1.25bn haematology acquisition, this week's deals reflect sustained biopharma investment in next-generation therapeutic platforms
  4. UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures Heligan Group's latest report records just 53 deals, down from 72 in Q1 2025, with pharma and life sciences remaining most active despite tighter financing conditions and prolonged deal timelines
  5. Safe and accurate flow measurement for pharmaceutical production Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity solvents to more viscous pharmaceutical ingredients

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Regulatory

Honeywell acquires life science-focused QMS provider

The acquisition further strengthens Honeywell's leadership in industrial automation, digital transformation solutions and enterprise performance management software
Analysis

When is gas potentially fatal?

Following a move to new premises with custom-built service facilities, Ashtead Technology has extended its RAE/Honeywell servicing capabilities to help customers ensure the accuracy and reliability of their gas detection activities
Manufacturing

Honeywell launches double-certified reference materials for calibration of laboratory instruments

New generation of Hydranal accredited under ISO Guide 34 simplifies calibration of instruments for research laboratories
Research & Development

Lab Innovations adds major names to its show stopping exhibitor line-up

Lab Innovations 2016 welcomes back an array of leading industry suppliers from across the UK, spanning the entire laboratory spectrum
Ingredients

Honeywell completes purchase of Sigma-Aldrich's Research Chemicals Business

Adds Fluka, Hydranal and Chromasolv brands to portfolio
Finance

ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment

The ARK Venture Fund has previously invested in tech platforms such as OpenAI and Anthropic and is now backing the life sciences company to solve cell therapy's scaling problem
Manufacturing

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Subscribe now